AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 41 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,725 | -7.3% | 14,853 | 0.0% | 0.00% | – |
Q2 2023 | $24,507 | +44.7% | 14,853 | 0.0% | 0.00% | – |
Q1 2023 | $16,932 | +26.4% | 14,853 | 0.0% | 0.00% | – |
Q4 2022 | $13,399 | -21.2% | 14,853 | 0.0% | 0.00% | – |
Q3 2022 | $17,000 | +70.0% | 14,853 | 0.0% | 0.00% | – |
Q2 2022 | $10,000 | -96.7% | 14,853 | -87.0% | 0.00% | – |
Q1 2022 | $299,000 | -33.0% | 114,623 | 0.0% | 0.00% | – |
Q4 2021 | $446,000 | -11.2% | 114,623 | -0.4% | 0.00% | – |
Q3 2021 | $502,000 | +9.4% | 115,043 | -0.6% | 0.00% | – |
Q2 2021 | $459,000 | -46.3% | 115,723 | -29.5% | 0.00% | – |
Q1 2021 | $854,000 | +77.2% | 164,259 | +82.5% | 0.00% | – |
Q4 2020 | $482,000 | +95.1% | 90,019 | +76.8% | 0.00% | – |
Q3 2020 | $247,000 | -14.2% | 50,926 | -14.1% | 0.00% | – |
Q2 2020 | $288,000 | +54.8% | 59,268 | +120.7% | 0.00% | – |
Q1 2019 | $186,000 | +72.2% | 26,849 | +56.8% | 0.00% | – |
Q4 2018 | $108,000 | – | 17,124 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |